Bi Asset Management Fondsmaeglerselskab A Eli Lilly & CO Transaction History

Bi Asset Management Fondsmaeglerselskab A

$5.77 Billion
Q3 2024

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Eli Lilly & CO stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 99,656 shares of LLY stock, worth $72.5 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares

99,656

Previous 56,641 75.94%

Holding current value

$72.5 Million

Previous $51.3 Million 72.16%

% of portfolio

1.53%

Previous 0.84%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $33.2 Million - $41.3 Million	43,015 Added 75.94%	99,656 $88.3 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $2.49 Million - $3.12 Million	3,431 Added 6.45%	56,641 $51.3 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $8.89 Million - $11.9 Million	15,018 Added 39.32%	53,210 $41.4 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $35.8 Million - $42.2 Million	-68,131 Reduced 64.08%	38,192 $22.3 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $3.93 Million - $5.42 Million	9,052 Added 9.31%	106,323 $57.1 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $2.88 Million - $3.85 Million	8,212 Added 9.22%	97,271 $45.6 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $14.1 Million - $16.6 Million	-45,377 Reduced 33.75%	89,059 $30.6 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $6.27 Million - $7.31 Million	19,504 Added 16.97%	134,436 $49.2 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $882,620 - $1.01 Million	2,977 Added 2.66%	114,932 $37.2 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $9.35 Million - $11 Million	-33,551 Reduced 23.06%	111,955 $36.3 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $2.05 Million - $2.55 Million	8,727 Added 6.38%	145,506 $41.7 Million
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $2.33 Million - $2.89 Million	-10,366 Reduced 7.04%	136,779 $37.8 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $4.91 Million - $6.05 Million	-22,169 Reduced 13.09%	147,145 $34 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $6.12 Million - $7.92 Million	-33,912 Reduced 16.69%	169,314 $38.9 Million
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $729,087 - $943,838	4,437 Added 2.23%	203,226 $38 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $3.08 Million - $4.07 Million	-23,603 Reduced 10.61%	198,789 $33.6 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $7.31 Million - $8.45 Million	49,990 Added 29.0%	222,392 $32.9 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $2.19 Million - $2.63 Million	-16,040 Reduced 8.51%	172,402 $28.3 Million
Q1 2020 May 11, 2020	SELL	$119.05 - $147.35 $6.86 Million - $8.49 Million	-57,626 Reduced 23.42%	188,442 $26.1 Million
Q4 2019 Mar 19, 2020	SELL	$106.92 - $132.43 $2.25 Million - $2.79 Million	-21,088 Reduced 7.89%	246,068 $32.3 Million
Q3 2019 Mar 19, 2020	BUY	$106.79 - $116.16 $4.25 Million - $4.63 Million	39,827 Added 17.52%	267,156 $29.9 Million
Q2 2019 Mar 19, 2020	BUY	$110.79 - $129.32 $4.38 Million - $5.12 Million	39,579 Added 21.08%	227,329 $25.2 Million
Q1 2019 Mar 19, 2020	BUY	$111.31 - $131.02 $4.44 Million - $5.22 Million	39,850 Added 26.94%	187,750 $24.4 Million
Q4 2018 Mar 19, 2020	SELL	$105.9 - $118.64 $3.13 Million - $3.51 Million	-29,600 Reduced 16.68%	147,900 $17.1 Million
Q3 2018 Mar 19, 2020	BUY	$85.86 - $107.31 $1.42 Million - $1.77 Million	16,500 Added 10.25%	177,500 $19 Million
Q2 2018 Mar 19, 2020	BUY	$75.7 - $86.88 $12.2 Million - $14 Million	161,000 New	161,000 $13.7 Million

Others Institutions Holding LLY

# of Institutions

4,002

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Eli Lilly & CO Transaction History